{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T11:11:54Z","timestamp":1784027514577,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jtha.2023.07.017","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T03:26:16Z","timestamp":1690946776000},"page":"3184-3192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Thrombophilia gene mutations predict venous thromboembolism in ambulatory cancer patients receiving chemotherapy"],"prefix":"10.1016","volume":"21","author":[{"given":"Danielle Carole","family":"Roy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Carrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjeeta","family":"Mallick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Hawken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip S.","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2023.07.017_bib1","series-title":"Hemostasis and thrombosis","author":"DeLoughery","year":"2019"},{"key":"10.1016\/j.jtha.2023.07.017_bib2","doi-asserted-by":"crossref","DOI":"10.1177\/2374289521990788","article-title":"Education case: hereditary thrombophilia with double heterozygous factor V Leiden and factor II c.\u221797G>A mutations","volume":"8","author":"Abukhiran","year":"2021","journal-title":"Acad Pathol"},{"key":"10.1016\/j.jtha.2023.07.017_bib3","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/ajh.10002","article-title":"Update on selected inherited venous thrombotic disorders","volume":"68","author":"Robetorye","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2023.07.017_bib4","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1521-6934(03)00010-5","article-title":"The inherited thrombophilias: genetics, epidemiology, and laboratory evaluation","volume":"17","author":"Buchanan","year":"2003","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.jtha.2023.07.017_bib5","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1016\/S0049-3848(07)70226-8","article-title":"PO-73 Prevalence of cancer and congenital thrombophilia in 435 patients with acute venous thromboembolism (VTE)","volume":"120","author":"Achkar","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2023.07.017_bib6","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/bjh.12575","article-title":"Prevalence of thrombophilia according to age at the first manifestation of venous thromboembolism: results from the MAISTHRO registry","volume":"163","author":"Weingarz","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2023.07.017_bib7","doi-asserted-by":"crossref","first-page":"340","DOI":"10.4174\/astr.2016.90.6.340","article-title":"Thrombophilia in Korean patients with arterial or venous thromboembolisms","volume":"90","author":"Kim","year":"2016","journal-title":"Ann Surg Treat Res"},{"key":"10.1016\/j.jtha.2023.07.017_bib8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/ijlh.13752","article-title":"The utility of hereditary thrombophilia testing among patients with unprovoked venous thromboembolism","volume":"44","author":"Olivo Freites","year":"2022","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jtha.2023.07.017_bib9","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1182\/blood.2020007338","article-title":"Venous thromboembolism in cancer patients: a population-based cohort study","volume":"137","author":"Mulder","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.07.017_bib10","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.5858\/arpa.2012-0490-RA","article-title":"Assessing the risk and prognosis of thrombotic complications in cancer patients","volume":"137","author":"Kyriazi","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jtha.2023.07.017_bib11","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/sj.bjc.6605599","article-title":"Epidemiology and pathophysiology of cancer-associated thrombosis","volume":"102","author":"Noble","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtha.2023.07.017_bib12","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1016\/j.thromres.2018.01.028","article-title":"Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer","volume":"164","author":"Lyman","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2023.07.017_bib13","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1814468","article-title":"Apixaban to prevent venous thromboembolism in patients with cancer","volume":"380","author":"Carrier","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.07.017_bib14","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1056\/NEJMoa1814630","article-title":"Rivaroxaban for thromboprophylaxis in high-risk ambulatory patients with cancer","volume":"380","author":"Khorana","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.07.017_bib15","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJMe1816060","article-title":"Direct oral anticoagulants for thromboprophylaxis in ambulatory patients with cancer","volume":"380","author":"Agnelli","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.07.017_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194973","article-title":"Risk of venous thromboembolism in association with factor V Leiden in cancer patients \u2013 the EDITH case-control study","volume":"13","author":"Heraudeau","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jtha.2023.07.017_bib17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/jth.12778","article-title":"Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients \u2013 results from the Vienna Cancer And Thrombosis Study (CATS)","volume":"13","author":"Pabinger","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.017_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00277-008-0569-6","article-title":"The 19-bp deletion of dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR) C677T, factor V Leiden, prothrombin G20210A polymorphisms in cancer patients with and without thrombosis","volume":"88","author":"Eroglu","year":"2009","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtha.2023.07.017_bib19","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1111\/jth.15011","article-title":"Combined effects of five prothrombotic genotypes and cancer on the risk of a first venous thromboembolic event","volume":"18","author":"Skille","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.017_bib20","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/s41416-018-0027-8","article-title":"Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer","volume":"118","author":"Mu\u00f1oz Mart\u00edn","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtha.2023.07.017_bib21","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.017_bib22","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.017_bib23","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3816\/SCT.2006.n.005","article-title":"Factor v Leiden mutation in patients with breast cancer with a central venous catheter: risk of deep vein thrombosis","volume":"3","author":"Curigliano","year":"2006","journal-title":"Support Cancer Ther"},{"key":"10.1016\/j.jtha.2023.07.017_bib24","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1002\/cncr.10590","article-title":"Impact of thrombophilic gene mutations on thrombosis risk in patients with gastrointestinal carcinoma","volume":"94","author":"Pihusch","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.jtha.2023.07.017_bib25","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jama.293.6.715","article-title":"Malignancies, prothrombotic mutations, and the risk of venous thrombosis","volume":"293","author":"Blom","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2023.07.017_bib26","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/cam4.513","article-title":"ABO non-O type as a risk factor for thrombosis in patients with pancreatic cancer","volume":"4","author":"Li","year":"2015","journal-title":"Cancer Med"},{"key":"10.1016\/j.jtha.2023.07.017_bib27","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.urology.2013.08.046","article-title":"Non-O blood type is associated with an increased risk of venous thromboembolism after radical cystectomy","volume":"83","author":"Wang","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.jtha.2023.07.017_bib28","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.thromres.2019.10.009","article-title":"Assessment of genetic and non-genetic risk factors for venous thromboembolism in glioblastoma \u2013 the predictive significance of B blood group","volume":"183","author":"Heenkenda","year":"2019","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2023.07.017_bib29","doi-asserted-by":"crossref","first-page":"6274","DOI":"10.1182\/bloodadvances.2021006283","article-title":"ABO blood group type and risk of venous thromboembolism in patients with cancer","volume":"6","author":"Englisch","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2023.07.017_bib30","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/369064a0","article-title":"Mutation in blood coagulation factor V associated with resistance to activated protein C","volume":"369","author":"Bertina","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.jtha.2023.07.017_bib31","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/ajh.24222","article-title":"Factor V Leiden","volume":"91","author":"Van Cott","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2023.07.017_bib32","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1182\/blood.2020005843","article-title":"The relationship between ABO blood group, von Willebrand factor, and primary hemostasis","volume":"136","author":"Ward","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.07.017_bib33","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The effect of ABO blood group on the diagnosis of von Willebrand disease","volume":"69","author":"Gill","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.07.017_bib34","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1182\/bloodadvances.2020003135","article-title":"Plasma levels of von Willebrand factor and future risk of incident venous thromboembolism","volume":"5","author":"Edvardsen","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2023.07.017_bib35","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.3324\/haematol.2019.224279","article-title":"Fibrinogen gamma gene rs2066865 and risk of cancer-related venous thromboembolism","volume":"105","author":"Paulsen","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2023.07.017_bib36","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.3324\/haematol.2016.147405","article-title":"Joint effects of cancer and variants in the factor 5 gene on the risk of venous thromboembolism","volume":"101","author":"Gran","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2023.07.017_bib37","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1111\/j.1538-7836.2009.03544.x","article-title":"Genetic variants associated with deep vein thrombosis: the F11 locus","volume":"7","author":"Li","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.017_bib38","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2141.2004.05327.x","article-title":"Factor V Leiden, prothrombin 20210A and the risk of venous thrombosis among cancer patients","volume":"128","author":"Kennedy","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2023.07.017_bib39","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/annonc\/mdp354","article-title":"Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial","volume":"21","author":"Mandal\u00e0","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtha.2023.07.017_bib40","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jtha.2022.12.021","article-title":"The risk of major bleeding in patients with factor V Leiden or prothrombin G20210A gene mutation while on extended anticoagulant treatment for VTE","volume":"21","author":"Caiano","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.017_bib41","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1182\/bloodadvances.2020002452","article-title":"Association of ABO blood group with bleeding severity in patients with bleeding of unknown cause","volume":"4","author":"Mehic","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2023.07.017_bib42","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/bloodadvances.2020003442","article-title":"American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer","volume":"5","author":"Lyman","year":"2021","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.jtha.2023.07.017_bib43","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1200\/JCO.19.01461","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update","volume":"38","author":"Key","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtha.2023.07.017_bib44","doi-asserted-by":"crossref","first-page":"e566","DOI":"10.1016\/S1470-2045(19)30336-5","article-title":"International Initiative on Thrombosis and Cancer (ITAC) advisory panel. 2019 International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer","volume":"20","author":"Farge","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtha.2023.07.017_bib45","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1002\/onco.13596","article-title":"Update on guidelines for the management of cancer-associated thrombosis","volume":"26","author":"Streiff","year":"2021","journal-title":"Oncologist"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623005809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623005809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:39:07Z","timestamp":1761536347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783623005809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1538783623005809"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2023.07.017","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombophilia gene mutations predict venous thromboembolism in ambulatory cancer patients receiving chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2023.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}